The Fight Against COVID19
21.98k followers • 14 symbols Watchlist by TREA
Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.
Curated by TREA
TREA analyzes over 100 million data points, interactions, relationships on company research and development activities, allowing investors to quickly gain insight without having to go through complex regulatory filings. Primary data sources include: FDA (Food and Drug Administration), NIH (National Institutes of Health), USPTO (US Patent and Trademark Office). The search parameters for generating this watchlist were (1) Above sector average Innovation Index score, (2) IP history at least 5 years (3) COVID19 (4) 2019-nCov (5) SARS-CoV-2 among others.
Performance
| Watchlist | Change Today | 1 Month Return | 1 Year Return | Total Return |
|---|---|---|---|---|
| The Fight Against COVID19 | +1.84% | - | - | - |
| ^GSPC | -0.15% | +0.58% | +33.27% | +4710.48% |
14 Symbols
| Symbol | Company Name | Last Price | Change | % Change | Market Time | Volume | Avg Vol (3 month) | Market Cap |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 165.22 | -0.20 | -0.12% | 4:00 p.m. EDT | 5.67M | 5.93M | 434.94B |
| PFE | Pfizer Inc. | 44.47 | -0.30 | -0.67% | 4:02 p.m. EDT | 21.96M | 31.49M | 249.33B |
| ABBV | AbbVie Inc. | 108.08 | +0.31 | +0.29% | 4:02 p.m. EDT | 5.67M | 6.86M | 191.00B |
| MRNA | Moderna, Inc. | 440.65 | +6.19 | +1.42% | 4:00 p.m. EDT | 10.11M | 17.82M | 177.87B |
| SNY | Sanofi | 48.19 | +0.18 | +0.37% | 4:00 p.m. EDT | 1.06M | 1.94M | 120.98B |
| GSK | GlaxoSmithKline plc | 39.11 | -0.11 | -0.28% | 4:00 p.m. EDT | 1.88M | 3.97M | 98.40B |
| BNTX | BioNTech SE | 372.65 | +17.40 | +4.90% | 4:00 p.m. EDT | 4.61M | 4.05M | 90.37B |
| GILD | Gilead Sciences, Inc. | 71.33 | -0.43 | -0.60% | 4:00 p.m. EDT | 5.16M | 6.09M | 89.43B |
| REGN | Regeneron Pharmaceuticals, Inc. | 653.18 | +1.18 | +0.18% | 4:00 p.m. EDT | 505.67k | 780.96k | 69.86B |
| TAK | Takeda Pharmaceutical Company Limited | 17.2 | +0.20 | +1.18% | 4:00 p.m. EDT | 2.28M | 1.77M | 54.34B |
| NVAX | Novavax, Inc. | 237.27 | +4.97 | +2.14% | 4:00 p.m. EDT | 2.22M | 4.91M | 17.67B |
| VIR | Vir Biotechnology, Inc. | 52.61 | +0.30 | +0.57% | 4:00 p.m. EDT | 785.82k | 916.70k | 6.87B |
| INO | Inovio Pharmaceuticals, Inc. | 7.75 | +0.18 | +2.38% | 4:00 p.m. EDT | 2.65M | 4.62M | 1.63B |
- Editor's PickYahoo Finance Video
COVID-19 infections 'rivaling' what happened in winter 2020: Doctor
Dr. Jabraan Pasha, internal medicine physician at University of Oklahoma Medical Center in Tulsa, joins the Yahoo Finance Live panel to discuss the latest COVID-19 developments
- Barrons.com
It’s Crunch Time for Booster Shots as FDA Committee Meets
Members are to vote on whether trial data support approval of a booster dose of the Pfizer vaccine six months after people received their second shot.
- Barrons.com
Sanofi Is Finally Catching Up. How a Covid Vaccine Could Lift the Stock.
Sanofi’s Covid vaccine is now in its Phase 3 trial, and the pharmaceutical company says results could come by the end of the year.
Sign in to view your followed lists
© 2021 Verizon Media. All rights reserved.
